Your browser does not support JavaScript! RENO CAPS CAPSULE [NNODUM PHARMACEUTICALS]
DailyMed Logo Header image

Daily Med

Current Medication Information

Options

RxNorm Names

RENO CAPS capsule
[Nnodum Pharmaceuticals]


Category DEA Schedule Marketing Status
HUMAN PRESCRIPTION DRUG LABEL unapproved drug other
NOTE:THIS DRUG HAS NOT BEEN FOUND BY FDA TO BE SAFE AND EFFECTIVE, AND THIS LABELING HAS NOT BEEN APPROVED BY FDA. For further information about unapproved drugs, click here.
Drug Label Sections

DESCRIPTION

Reno Caps are black oval softgel imprinted “z622”. These softgels provide water- soluble vitamins.

Active Ingredients:

Each Reno Caps softgel contains:

Vitamin C (Ascorbic Acid)………………………100 mg

Thiamine (as thiamine mononitrate)……………..1.5 mg

Riboflavin………………………………………..1.7 mg

Niacin (as niacinamide)………………………….20 mg

Vitamin B-6 (as pyridoxine Hcl)………………...10 mg

Folate (as folic Acid)…………………………….1 mg

Vitamin B-12 (as cyanocobalam)………………..6 mcg

Biotin……………………………………………..150 mcg

Pantothenic acid (as calcium Pantothenate)……...5 mg

Inactive Ingredients: Gelatin, glycerin, lecithin, soybean oil, yellow beeswax, titanium dioxide, FDC Yellow #6, water, FDC blue #1, FDC Red #40

INDICATIONS

Reno Caps Softgels is a prescription vitamins supplement indicated for renal disease patients to replace critical vitamins lost due to dialysis in patients with chronic renal disease, uremia and impaired metabolic kidney functions. Also used as a stress vitamin.

PRECAUTIONS

Folic acid may mask the symptoms of pernicious anemia in that hematologic remission may occur while neurological manifestations progess.

DOSAGE AND ADMINISTRATION

One softgel daily, or as directed by a physician. If on dialysis, take after treatment.

Storage: Store at controlled room temperature 15-30C (59-86 F). Keep container tightly closed and protect from heat and moisture.

KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN

Manufactured by :

Catalent Australia PTY LTD

Distributed by:

Nnodum Pharmaceuticals 

Cincinnati, Ohio 45240

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

71d7f6ee-figure-01
RENO CAPS  
reno caps capsule
Product Information
Product TypeHUMAN PRESCRIPTION DRUG LABELItem Code (Source)NDC:63044-622
Route of AdministrationORALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
ASCORBIC ACID (ASCORBIC ACID) ASCORBIC ACID100 mg
THIAMINE (THIAMINE ION) THIAMINE1.5 mg
RIBOFLAVIN (RIBOFLAVIN) RIBOFLAVIN1.7 mg
NIACIN (NIACIN) NIACIN20 mg
PYRIDOXINE (PYRIDOXINE) PYRIDOXINE10 mg
FOLIC ACID (FOLIC ACID) FOLIC ACID1 mg
BIOTIN (BIOTIN) BIOTIN150 ug
PANTOTHENIC ACID (PANTOTHENIC ACID) PANTOTHENIC ACID5 mg
CYANOCOBALAMIN (CYANOCOBALAMIN) CYANOCOBALAMIN6 ug
Inactive Ingredients
Ingredient NameStrength
GELATIN 
GLYCERIN 
LECITHIN, SOYBEAN 
SOYBEAN OIL 
TITANIUM DIOXIDE 
FD&C YELLOW NO. 6 
WATER 
FD&C BLUE NO. 1 
FD&C RED NO. 40 
Product Characteristics
ColorBLACKScoreno score
ShapeOVALSize7mm
FlavorImprint Code z622
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:63044-622-01100 in 1 BOTTLE
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
Unapproved drug other11/30/2008
Labeler - Nnodum Pharmaceuticals (960457273)
Registrant - Nnodum Pharmaceuticals (960457273)
Establishment
NameAddressID/FEIBusiness Operations
Catalent Australia PTY LTD753617638ANALYSIS(63044-622), MANUFACTURE(63044-622)
Establishment
NameAddressID/FEIBusiness Operations
Banner Pharmacaps242721744ANALYSIS(63044-622), MANUFACTURE(63044-622)

Revised: 11/2013
 
Nnodum Pharmaceuticals

Visit The National Library of Medicine Copyright, Privacy, Accessibility
U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894
National Institutes of Health, Health & Human Services